A global research priority agenda to advance public health responses to fatty liver disease

Autores
Lazarus, Jeffrey V.; Mark, Henry E.; Allen, Alina M.; Arab, Juan Pablo; Carrieri, Patrizia; Noureddin, Mazen; Alazawi, William; Alkhouri, Naim; Alqahtani, Saleh A.; Arrese, Marco; Bataller, Ramon; Berg, Thomas; Brennan, Paul N.; Burra, Patrizia; Castro Narro, Graciela E.; Cortez Pinto, Helena; Cusi, Kenneth; Dedes, Nikos; Duseja, Ajay; Francque, Sven M.; Hagström, Hannes; Huang, Terry T. K.; Wajcman, Dana Ivancovsky; Valenti, Luca; Zelber-Sagi, Shira; Schattenberg, Jörn M.; Wong, Vincent Wai-Sun; Younossi, Zobair M.; Zheng, Kenneth I.; Sookoian, Silvia Cristina
Año de publicación
2023
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background & aims: An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. Methods: Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a threeday in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. Results: The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a supermajority of agreement (>66.7% ‘agree’), 13 priorities had <80% ‘agree’, with greater reliance on ‘somewhat agree’ to achieve >90% combined agreement. Conclusions: Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community’s efforts to advance and accelerate responses to this widespread and fast-growing public health threat.
Fil: Lazarus, Jeffrey V.. City University of New York; Estados Unidos. Universidad de Barcelona; España
Fil: Mark, Henry E.. European Association for the Study of the Liver; Suiza
Fil: Allen, Alina M.. Mayo Clinic; Estados Unidos
Fil: Arab, Juan Pablo. Pontificia Universidad Católica de Chile; Chile. Western University; Canadá
Fil: Carrieri, Patrizia. Inserm; Francia. Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale; Francia
Fil: Noureddin, Mazen. Houston Methodist Hospital; Estados Unidos
Fil: Alazawi, William. Queen Mary University of London; Estados Unidos
Fil: Alkhouri, Naim. Arizona Liver Health; Estados Unidos
Fil: Alqahtani, Saleh A.. King Faisal Specialist Hospital And Research Centre; Arabia Saudita
Fil: Arrese, Marco. Universidad Católica de Chile; Chile. Pontificia Universidad Católica de Chile; Chile
Fil: Bataller, Ramon. Universidad de Barcelona; España
Fil: Berg, Thomas. Universitat Leipzig; Alemania
Fil: Brennan, Paul N.. University of Dundee; Reino Unido
Fil: Burra, Patrizia. Università di Padova; Italia
Fil: Castro Narro, Graciela E.. Instituto Nacional de la Nutrición Salvador Zubiran; México. Fundacion Clinica Medica Sur; México. Asociación Latinoamericana Para El Estudio del Hígado; Chile
Fil: Cortez Pinto, Helena. Universidade Nova de Lisboa; Portugal
Fil: Cusi, Kenneth. University of Florida; Estados Unidos
Fil: Dedes, Nikos. Greek Patients Association; Grecia
Fil: Duseja, Ajay. Postgraduate Institute of Medical Education and Research; India
Fil: Francque, Sven M.. Universiteit Antwerp; Bélgica
Fil: Hagström, Hannes. Karolinska Huddinge Hospital. Karolinska Institutet; Suecia
Fil: Huang, Terry T. K.. City University of New York; Estados Unidos
Fil: Wajcman, Dana Ivancovsky. Universidad de Barcelona; España
Fil: Valenti, Luca. Università degli Studi di Milano; Italia
Fil: Zelber-Sagi, Shira. University Of Haifa; Israel. Universitat Tel Aviv; Israel
Fil: Schattenberg, Jörn M.. Johannes Gutenberg Universitat Mainz; Alemania
Fil: Wong, Vincent Wai-Sun. Chinese University Of Hong Kong; Hong Kong
Fil: Younossi, Zobair M.. Universiteit Antwerp; Bélgica
Fil: Zheng, Kenneth I.. Universiteit Antwerp; Bélgica
Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Universidad Abierta Interamericana; Argentina
Materia
DELPHI METHOD
GLOBAL HEALTH
NAFLD/NASH
NON-COMMUNICABLE DISEASE (NCD)
STEATOTIC LIVER DISEASE
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/240520

id CONICETDig_31b1d687f39b0649b5f4312ace3a2f7f
oai_identifier_str oai:ri.conicet.gov.ar:11336/240520
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling A global research priority agenda to advance public health responses to fatty liver diseaseLazarus, Jeffrey V.Mark, Henry E.Allen, Alina M.Arab, Juan PabloCarrieri, PatriziaNoureddin, MazenAlazawi, WilliamAlkhouri, NaimAlqahtani, Saleh A.Arrese, MarcoBataller, RamonBerg, ThomasBrennan, Paul N.Burra, PatriziaCastro Narro, Graciela E.Cortez Pinto, HelenaCusi, KennethDedes, NikosDuseja, AjayFrancque, Sven M.Hagström, HannesHuang, Terry T. K.Wajcman, Dana IvancovskyValenti, LucaZelber-Sagi, ShiraSchattenberg, Jörn M.Wong, Vincent Wai-SunYounossi, Zobair M.Zheng, Kenneth I.Sookoian, Silvia CristinaDELPHI METHODGLOBAL HEALTHNAFLD/NASHNON-COMMUNICABLE DISEASE (NCD)STEATOTIC LIVER DISEASEhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background & aims: An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. Methods: Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a threeday in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. Results: The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a supermajority of agreement (>66.7% ‘agree’), 13 priorities had <80% ‘agree’, with greater reliance on ‘somewhat agree’ to achieve >90% combined agreement. Conclusions: Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community’s efforts to advance and accelerate responses to this widespread and fast-growing public health threat.Fil: Lazarus, Jeffrey V.. City University of New York; Estados Unidos. Universidad de Barcelona; EspañaFil: Mark, Henry E.. European Association for the Study of the Liver; SuizaFil: Allen, Alina M.. Mayo Clinic; Estados UnidosFil: Arab, Juan Pablo. Pontificia Universidad Católica de Chile; Chile. Western University; CanadáFil: Carrieri, Patrizia. Inserm; Francia. Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale; FranciaFil: Noureddin, Mazen. Houston Methodist Hospital; Estados UnidosFil: Alazawi, William. Queen Mary University of London; Estados UnidosFil: Alkhouri, Naim. Arizona Liver Health; Estados UnidosFil: Alqahtani, Saleh A.. King Faisal Specialist Hospital And Research Centre; Arabia SauditaFil: Arrese, Marco. Universidad Católica de Chile; Chile. Pontificia Universidad Católica de Chile; ChileFil: Bataller, Ramon. Universidad de Barcelona; EspañaFil: Berg, Thomas. Universitat Leipzig; AlemaniaFil: Brennan, Paul N.. University of Dundee; Reino UnidoFil: Burra, Patrizia. Università di Padova; ItaliaFil: Castro Narro, Graciela E.. Instituto Nacional de la Nutrición Salvador Zubiran; México. Fundacion Clinica Medica Sur; México. Asociación Latinoamericana Para El Estudio del Hígado; ChileFil: Cortez Pinto, Helena. Universidade Nova de Lisboa; PortugalFil: Cusi, Kenneth. University of Florida; Estados UnidosFil: Dedes, Nikos. Greek Patients Association; GreciaFil: Duseja, Ajay. Postgraduate Institute of Medical Education and Research; IndiaFil: Francque, Sven M.. Universiteit Antwerp; BélgicaFil: Hagström, Hannes. Karolinska Huddinge Hospital. Karolinska Institutet; SueciaFil: Huang, Terry T. K.. City University of New York; Estados UnidosFil: Wajcman, Dana Ivancovsky. Universidad de Barcelona; EspañaFil: Valenti, Luca. Università degli Studi di Milano; ItaliaFil: Zelber-Sagi, Shira. University Of Haifa; Israel. Universitat Tel Aviv; IsraelFil: Schattenberg, Jörn M.. Johannes Gutenberg Universitat Mainz; AlemaniaFil: Wong, Vincent Wai-Sun. Chinese University Of Hong Kong; Hong KongFil: Younossi, Zobair M.. Universiteit Antwerp; BélgicaFil: Zheng, Kenneth I.. Universiteit Antwerp; BélgicaFil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Universidad Abierta Interamericana; ArgentinaElsevier Science2023-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/240520Lazarus, Jeffrey V.; Mark, Henry E.; Allen, Alina M.; Arab, Juan Pablo; Carrieri, Patrizia; et al.; A global research priority agenda to advance public health responses to fatty liver disease; Elsevier Science; Journal of Hepatology; 79; 3; 9-2023; 618-6340168-8278CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.jhep.2023.04.035info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0168827823003239info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:18:25Zoai:ri.conicet.gov.ar:11336/240520instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:18:25.747CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv A global research priority agenda to advance public health responses to fatty liver disease
title A global research priority agenda to advance public health responses to fatty liver disease
spellingShingle A global research priority agenda to advance public health responses to fatty liver disease
Lazarus, Jeffrey V.
DELPHI METHOD
GLOBAL HEALTH
NAFLD/NASH
NON-COMMUNICABLE DISEASE (NCD)
STEATOTIC LIVER DISEASE
title_short A global research priority agenda to advance public health responses to fatty liver disease
title_full A global research priority agenda to advance public health responses to fatty liver disease
title_fullStr A global research priority agenda to advance public health responses to fatty liver disease
title_full_unstemmed A global research priority agenda to advance public health responses to fatty liver disease
title_sort A global research priority agenda to advance public health responses to fatty liver disease
dc.creator.none.fl_str_mv Lazarus, Jeffrey V.
Mark, Henry E.
Allen, Alina M.
Arab, Juan Pablo
Carrieri, Patrizia
Noureddin, Mazen
Alazawi, William
Alkhouri, Naim
Alqahtani, Saleh A.
Arrese, Marco
Bataller, Ramon
Berg, Thomas
Brennan, Paul N.
Burra, Patrizia
Castro Narro, Graciela E.
Cortez Pinto, Helena
Cusi, Kenneth
Dedes, Nikos
Duseja, Ajay
Francque, Sven M.
Hagström, Hannes
Huang, Terry T. K.
Wajcman, Dana Ivancovsky
Valenti, Luca
Zelber-Sagi, Shira
Schattenberg, Jörn M.
Wong, Vincent Wai-Sun
Younossi, Zobair M.
Zheng, Kenneth I.
Sookoian, Silvia Cristina
author Lazarus, Jeffrey V.
author_facet Lazarus, Jeffrey V.
Mark, Henry E.
Allen, Alina M.
Arab, Juan Pablo
Carrieri, Patrizia
Noureddin, Mazen
Alazawi, William
Alkhouri, Naim
Alqahtani, Saleh A.
Arrese, Marco
Bataller, Ramon
Berg, Thomas
Brennan, Paul N.
Burra, Patrizia
Castro Narro, Graciela E.
Cortez Pinto, Helena
Cusi, Kenneth
Dedes, Nikos
Duseja, Ajay
Francque, Sven M.
Hagström, Hannes
Huang, Terry T. K.
Wajcman, Dana Ivancovsky
Valenti, Luca
Zelber-Sagi, Shira
Schattenberg, Jörn M.
Wong, Vincent Wai-Sun
Younossi, Zobair M.
Zheng, Kenneth I.
Sookoian, Silvia Cristina
author_role author
author2 Mark, Henry E.
Allen, Alina M.
Arab, Juan Pablo
Carrieri, Patrizia
Noureddin, Mazen
Alazawi, William
Alkhouri, Naim
Alqahtani, Saleh A.
Arrese, Marco
Bataller, Ramon
Berg, Thomas
Brennan, Paul N.
Burra, Patrizia
Castro Narro, Graciela E.
Cortez Pinto, Helena
Cusi, Kenneth
Dedes, Nikos
Duseja, Ajay
Francque, Sven M.
Hagström, Hannes
Huang, Terry T. K.
Wajcman, Dana Ivancovsky
Valenti, Luca
Zelber-Sagi, Shira
Schattenberg, Jörn M.
Wong, Vincent Wai-Sun
Younossi, Zobair M.
Zheng, Kenneth I.
Sookoian, Silvia Cristina
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv DELPHI METHOD
GLOBAL HEALTH
NAFLD/NASH
NON-COMMUNICABLE DISEASE (NCD)
STEATOTIC LIVER DISEASE
topic DELPHI METHOD
GLOBAL HEALTH
NAFLD/NASH
NON-COMMUNICABLE DISEASE (NCD)
STEATOTIC LIVER DISEASE
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Background & aims: An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. Methods: Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a threeday in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. Results: The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a supermajority of agreement (>66.7% ‘agree’), 13 priorities had <80% ‘agree’, with greater reliance on ‘somewhat agree’ to achieve >90% combined agreement. Conclusions: Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community’s efforts to advance and accelerate responses to this widespread and fast-growing public health threat.
Fil: Lazarus, Jeffrey V.. City University of New York; Estados Unidos. Universidad de Barcelona; España
Fil: Mark, Henry E.. European Association for the Study of the Liver; Suiza
Fil: Allen, Alina M.. Mayo Clinic; Estados Unidos
Fil: Arab, Juan Pablo. Pontificia Universidad Católica de Chile; Chile. Western University; Canadá
Fil: Carrieri, Patrizia. Inserm; Francia. Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale; Francia
Fil: Noureddin, Mazen. Houston Methodist Hospital; Estados Unidos
Fil: Alazawi, William. Queen Mary University of London; Estados Unidos
Fil: Alkhouri, Naim. Arizona Liver Health; Estados Unidos
Fil: Alqahtani, Saleh A.. King Faisal Specialist Hospital And Research Centre; Arabia Saudita
Fil: Arrese, Marco. Universidad Católica de Chile; Chile. Pontificia Universidad Católica de Chile; Chile
Fil: Bataller, Ramon. Universidad de Barcelona; España
Fil: Berg, Thomas. Universitat Leipzig; Alemania
Fil: Brennan, Paul N.. University of Dundee; Reino Unido
Fil: Burra, Patrizia. Università di Padova; Italia
Fil: Castro Narro, Graciela E.. Instituto Nacional de la Nutrición Salvador Zubiran; México. Fundacion Clinica Medica Sur; México. Asociación Latinoamericana Para El Estudio del Hígado; Chile
Fil: Cortez Pinto, Helena. Universidade Nova de Lisboa; Portugal
Fil: Cusi, Kenneth. University of Florida; Estados Unidos
Fil: Dedes, Nikos. Greek Patients Association; Grecia
Fil: Duseja, Ajay. Postgraduate Institute of Medical Education and Research; India
Fil: Francque, Sven M.. Universiteit Antwerp; Bélgica
Fil: Hagström, Hannes. Karolinska Huddinge Hospital. Karolinska Institutet; Suecia
Fil: Huang, Terry T. K.. City University of New York; Estados Unidos
Fil: Wajcman, Dana Ivancovsky. Universidad de Barcelona; España
Fil: Valenti, Luca. Università degli Studi di Milano; Italia
Fil: Zelber-Sagi, Shira. University Of Haifa; Israel. Universitat Tel Aviv; Israel
Fil: Schattenberg, Jörn M.. Johannes Gutenberg Universitat Mainz; Alemania
Fil: Wong, Vincent Wai-Sun. Chinese University Of Hong Kong; Hong Kong
Fil: Younossi, Zobair M.. Universiteit Antwerp; Bélgica
Fil: Zheng, Kenneth I.. Universiteit Antwerp; Bélgica
Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Universidad Abierta Interamericana; Argentina
description Background & aims: An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. Methods: Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a threeday in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. Results: The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a supermajority of agreement (>66.7% ‘agree’), 13 priorities had <80% ‘agree’, with greater reliance on ‘somewhat agree’ to achieve >90% combined agreement. Conclusions: Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community’s efforts to advance and accelerate responses to this widespread and fast-growing public health threat.
publishDate 2023
dc.date.none.fl_str_mv 2023-09
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/240520
Lazarus, Jeffrey V.; Mark, Henry E.; Allen, Alina M.; Arab, Juan Pablo; Carrieri, Patrizia; et al.; A global research priority agenda to advance public health responses to fatty liver disease; Elsevier Science; Journal of Hepatology; 79; 3; 9-2023; 618-634
0168-8278
CONICET Digital
CONICET
url http://hdl.handle.net/11336/240520
identifier_str_mv Lazarus, Jeffrey V.; Mark, Henry E.; Allen, Alina M.; Arab, Juan Pablo; Carrieri, Patrizia; et al.; A global research priority agenda to advance public health responses to fatty liver disease; Elsevier Science; Journal of Hepatology; 79; 3; 9-2023; 618-634
0168-8278
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jhep.2023.04.035
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0168827823003239
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier Science
publisher.none.fl_str_mv Elsevier Science
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844614145991770112
score 13.070432